Medical imaging tech firm Nano-X misses Q3 revenue estimates

Nano-X Imaging

20/11/2025 13:08

Overview

Nano-X Q3 revenue rose to $3.4 mln but missed analyst expectations

Adjusted net income for Q3 beat analyst estimates

Company acquired Vaso Healthcare IT to enhance AI solutions business

Outlook

Company expects to deploy over 100 units globally by end of 2025

Company anticipates 2026 revenue to reach $35 mln

Result Drivers

TELERADIOLOGY SERVICES - Increased revenue from teleradiology services attributed to customer retention and higher service rates

VASO HEALTHCARE IT ACQUISITION - Acquisition aims to expand AI solutions business

COMMERCIAL COLLABORATIONS - New partnerships to accelerate commercialization of Nanox.ARC and AI solutions globally

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$3.40 mln
$3.50 mln (3 Analysts)
Q3 Adjusted Net Income
Beat
-$9.90 mln
-$13.66 mln (3 Analysts)
Q3 Net Income
-$13.70 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Nano-X Imaging Ltd is $7.50, about 59.6% above its November 19 closing price of $3.03

Press Release: ID:nGNX8FklDM

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)